Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Vincent and Jason review influenza 2009 H1N1 vaccine trials and protection against the virus conferred by the 1976 swine flu vaccine, then move on to a virus called XMRV and its possible role in prostate cancer.
Links for this episode:- One dose of influenza 2009 H1N1 vaccine without adjuvant is enough
- Partially completed study on influenza 2009 H1N1 vaccine with MF59 adjuvant
- 1976 swine flu vaccine induces cross-reactive antibodies against influenza 2009 H1N1 strain
- Explanation of hemagglutination-inhibition and microneutralization assays
- FDA approves influenza 2009 H1N1 vaccine
- XMRV is present in malignant prostatic epithelium and is associated with prostate cancer
- Identification of a novel gammaretrovirus in prostate tumors
- CDC page on Guillain-Barré syndrome
Jason Glass MicrobiologyVincent FluWeb Influenza Historical Resources Database